Sildenafil relaxes rabbit clitoral corpus cavernosum.

Area of Science:

• Pharmacology
• Neuroscience
• Urology

Background:

• Female sexual dysfunction (FSD) is a complex condition with various contributing factors.
• The nitric oxide-cyclic guanosine monophosphate (NO-cGMP) pathway is crucial for smooth muscle relaxation, including in the clitoris.
• Understanding the mechanisms of clitoral function is essential for developing effective FSD treatments.

Purpose of the Study:

• To investigate the role of phosphodiesterase type 5 (PDE5) inhibition in modulating female sexual function.
• To determine the effects of sildenafil on in vitro clitoral relaxation.
• To elucidate the specific signaling pathways involved in PDE5 inhibition-mediated clitoral responses.

Main Methods:

• In vitro assessment of rabbit clitoral corpus cavernosum strips.
• Electrical field stimulation (EFS) to induce neuronal-mediated relaxation.
• Pharmacological blockade of nitric oxide synthase (NOS) with L-NAME and soluble guanylate cyclase (sGC) with ODQ.
• Assessment of tetrodotoxin's effect on EFS-induced relaxation.
• Evaluation of sildenafil's impact on EFS-induced clitoral relaxation.

Main Results:

• EFS induced frequency-dependent clitoral relaxation, mediated by the NO-cGMP pathway.
• Inhibition of NOS and sGC significantly abolished EFS-induced relaxation.
• Tetrodotoxin blocked EFS-induced relaxation, confirming neuronal nitric oxide release.
• Sildenafil pretreatment enhanced the magnitude and duration of EFS-induced clitoral relaxations.

Conclusions:

• Sildenafil enhances EFS-induced clitoral relaxation through a NO-cGMP dependent mechanism.
• Neuronal nitric oxide release plays a significant role in clitoral smooth muscle relaxation.
• These findings suggest that PDE5 inhibitors like sildenafil may offer a therapeutic strategy for treating female sexual dysfunction.